After completing 2-month Yoga course, CISF jawan kills 4 colleagues

Bengaluru, Jan 15: The Indian startups secured 12.7 billion in funding last year -- a 15% growth compared to 2018 - and Bengaluru startup community topped the list, with securing $5.3 billion across 267 deals, a new report said on Tuesday.

In total, the Indian startups attracted 766 deals in 2019, taking total deal count between 2014-2019 to 5,011, said DataLabs by Inc42 in its annual startup funding report.

Sequoia took the top spot as the most active VC in 2019 with 53 deals, followed by Accel that participated in 38 deals. Blume Ventures, Matrix Partners and Tiger Global were in the top five VCs in 2019.

"The Indian startup economy is entering new decade with over $58 billion in fundraising and 2,984 funded startups between 2014-2019," the findings showed.

With an average of $21 million, the ticket size value of funding increased by 15% in 2019.

Ecommerce and fintech -- with $2.6 billion funding each -- took the top slot with 93 deals and 125 deals, respectively.

"Ecommerce continued to remain at the top by the end of 2019. The growing investor confidence towards sub-sectors such as vertical ecommerce, social commerce and private label businesses is one major factor for ecommerce maintaining its lead," a DataLabs spokesperson said in a statement.

According to the estimates, the funding amount and deal count in 2020 will be around $12.6 billion at a 1% decline from 2019.

"Nevertheless, the investment activity is expected to rise in 2021," said the report.

The data suggests that 2019 had lowest number of startups funded (664) in the last five years, with seed-stage funding deals dropping by 53%, compared to 2016.

With $252 million in funding, seed-stage deal value fell by 44% (compared to 2018) as only 306 seed funding deals were recorded, the report said.

The enterprise tech had a blockbuster year with total funding of $1.15 billion across 114 deals in 2019. The sector recorded a 49% surge in total funding amount, compared to 2018.

The Indian startup economy saw 275 unique VCs participating in funding in 2019, said the report.

Bengaluru, Mar 28: Karnataka Director General of Police Praveen Sood on Saturday asked philanthropists who want to support the poor during the lockdown to leave food at the nearby police station, who will ensure that it reaches the needy.

The DGP has asked the Bengaluru City police Commissioner to take steps in this regard and ensure fair distribution.

"All philanthropists, in case you want to support poor. Leave cooked, packed, simple food at the police station and it will reach poor. @CPBlr pl announce a nodal officer for deciding the police station for fair distribution," Sood wrote on his official twitter handle.

Responding to the DGP's tweet, city police Commissioner Bhaskar Rao appointed Joint Commissioner (Crime) as a nodal officer.

"Sandeep Patil, IPS, Joint Commissioner, CRIME at 9480801011 is the officer nominated from Bangalore City Police to receive and acknowledge donation of food and consumables for distribution to police and those in need," Rao tweeted.

Meanwhile, the city police has also initiated measures to take those in critical medical emergency to the nearest medical facility.

"We @BlrCityPolice are at your service 24/7 to take you to nearest medical facility in critical medical emergency, dialysis, chemo, emergent heart issues etc PLEASE CALL 100 Misuse may affect someones life! Be responsible #CoronaLockdown is National Duty #Covid19India," Additional Commissioner of Police (Administration), Bengaluru, Hemant Nimbalkar tweeted.

Bengaluru police's initiative of distributing food, snacks, water and certain essential requirements to those in need has received wide appreciation.

While some police stations are already providing food to poor and those in need by collecting it from sponsors, couple of them have even hired a cook for the needy.

The lockdown has affected the poor who depend on their daily wages for livelihood.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.